Half-year report · HY
7129.TEDINET S100X0ZA
Period2025-04-01 → 2025-09-30
Filed2025-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥23.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥193m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥125m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥197m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥645m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥120m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥200m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥168m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥140m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥300m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥112m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥140m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥112m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥12.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥13.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥13.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.6bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥9.5bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥503m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥174m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥117m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥456m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥217m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥588m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥853m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥425m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥50.03 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.95 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.61 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥49.93 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥113.05 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.14 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥509m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥477m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥32m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥7m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥32m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥32m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥514m |
| Childcaresupport Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.9bn |
| Childcaresupport Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.9bn |
| Childcaresupport Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥471m |
| Medicinereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.8bn |
| Medicinereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.8bn |
| Medicinereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥203m |
| Nursing Care Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥27m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥11.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥11.5bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥701m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥32m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥708m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥468m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥444m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥10m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥24m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥493m |
| Childcaresupport Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Childcaresupport Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Childcaresupport Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥364m |
| Medicinereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Medicinereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Medicinereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥266m |
| Nursing Care Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥22m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥608m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥618m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 545
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 547000 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.1956 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 100000 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.0357 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 100000 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0357 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 60000 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0214 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 55600 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0198 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 40000 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0143 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 40000 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0143 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 27000 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0096 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 21000 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0075 | |
| Number of shares held | InterimInstant | 1826700 | |
| Shareholding ratio | InterimInstant | 0.6532 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 100 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 27950 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 2795000 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 1200 | |
| Number of shares issued shares voting rights | InterimInstant | 2796300 | |
| Number of voting rights issued shares voting rights | InterimInstant | 27950 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 100 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 100 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 100 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 100 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant | 1625812000 | JPY |
| Cash and deposits | InterimInstant | 1370919000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 2817774000 | JPY |
| Accounts receivable trade | InterimInstant | 2403417000 | JPY |
| Merchandise | Prior1YearInstant | 397685000 | JPY |
| Merchandise | InterimInstant | 384760000 | JPY |
| Supplies | Prior1YearInstant | 18389000 | JPY |
| Supplies | InterimInstant | 20510000 | JPY |
| Accounts receivable other | Prior1YearInstant | 163391000 | JPY |
| Accounts receivable other | InterimInstant | 160268000 | JPY |
| Other ca | Prior1YearInstant | 438582000 | JPY |
| Other ca | InterimInstant | 490490000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |